Enlightment of routine vaccination under the prevention and control of COVID-19 based on the circulating event of type Ⅲ vaccine-derived poliovirus in Shanghai.
10.3760/cma.j.cn112150-20210809-00772
- Author:
Xiang GUO
1
;
Zhi LI
1
;
JianPing YANG
1
;
JiaYu HU
1
;
ZhuoYing HUANG
1
;
Jing QIU
1
;
XiaoYing MA
1
;
JianFang DUAN
2
;
XiaoDong SUN
1
Author Information
1. Department of Immunization Program, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China.
2. Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China.
- Publication Type:Journal Article
- MeSH:
COVID-19;
China;
Humans;
Poliovirus;
Poliovirus Vaccine, Oral;
SARS-CoV-2;
Vaccination
- From:
Chinese Journal of Preventive Medicine
2021;55(12):1377-1382
- CountryChina
- Language:Chinese
-
Abstract:
Since the Global Polio Eradication Initiative was launched by the World Health Assembly in 1988, significant progress has been made in global polio prevention and control. But the occurrence of vaccine-associated paralytic poliomyelitis cases and vaccine-derived poliovirus related cases have become a major challenge during the post-polio era. While coronavirus disease 2019(COVID-19) has brought serious disease burden and economic burden to all countries in the world, prevention and control of vaccine-preventable infectious diseases such as polio should not be neglected under the background of the global common fight against COVID-19. Taking the type Ⅲ VDPV cycle event in Shanghai as an example, the paper discussed how to do a good job of routine inoculation under the prevention and control of COVID-19 to strictly prevent the outbreak of vaccine-preventable infectious diseases.
